4-butyrolactone has been researched along with oxidopamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harsing, LG; Vizi, ES | 1 |
| Greiner, HE; Haase, AF; Seyfried, CA | 1 |
| Hong, JS; Hudson, PM; Nanry, KP; Stachowiak, MK; Tilson, HA; Zhang, WQ | 1 |
| Fillenz, M; O'Neill, RD | 1 |
| Altar, CA; Marshall, JF; O'Neil, S | 1 |
| Haubrich, DR; Martin, GE; Williams, M | 1 |
| Hirose, T; Kikuchi, T; Miwa, T; Morita, S; Oshiro, Y; Tottori, K; Uwahodo, Y | 1 |
7 other study(ies) available for 4-butyrolactone and oxidopamine
| Article | Year |
|---|---|
Alpha 2-adrenoceptors are not involved in the regulation of striatal glutamate release: comparison to dopaminergic inhibition.
Topics: 4-Butyrolactone; Animals; Apomorphine; Berberine; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Drug Interactions; Glutamates; Glutamic Acid; Haloperidol; Hydrazines; Hydroxydopamines; Male; Oxidopamine; Potassium Chloride; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Secretory Rate; Synaptic Transmission; Yohimbine | 1991 |
Biochemical and functional studies on EMD 49,980: a potent, selectively presynaptic D-2 dopamine agonist with actions on serotonin systems.
Topics: 4-Butyrolactone; 5-Hydroxytryptophan; Acetylcholine; Animals; Brain Chemistry; Dihydroxyphenylalanine; Dopamine Agents; Hippocampus; Hydroxydopamines; Indoles; Male; Oxidopamine; Oxindoles; p-Chloroamphetamine; Pyridines; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Synaptosomes | 1989 |
Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
Topics: 4-Butyrolactone; Animals; Corpus Striatum; Dopamine; Furans; Haloperidol; Homovanillic Acid; Hydroxydopamines; Male; Oxidopamine; Potassium Chloride; Rats; Rats, Inbred F344; Substantia Nigra | 1988 |
Detection of homovanillic acid in vivo using microcomputer-controlled voltammetry: simultaneous monitoring of rat motor activity and striatal dopamine release.
Topics: 4-Butyrolactone; alpha-Methyltyrosine; Animals; Computers; Corpus Striatum; Dopamine; Electrochemistry; Homovanillic Acid; Hydroxydopamines; Male; Methyltyrosines; Motor Activity; Neural Pathways; Oxidopamine; Phenylacetates; Rats; Rats, Inbred Strains; Substantia Nigra | 1985 |
Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Biotransformation; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxybutyrates; Hydroxydopamines; Male; Microinjections; Oxidopamine; Procaine; Psychomotor Performance; Rats; Rats, Inbred Strains; Sodium Oxybate; Substantia Nigra | 1984 |
A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
Topics: 4-Butyrolactone; Animals; Apomorphine; Cell Membrane; Corpus Striatum; Female; Humans; Hydroxydopamines; Naphthalenes; Oxidopamine; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Tetrahydronaphthalenes | 1982 |
7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Catalepsy; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxidopamine; Piperazines; Presynaptic Terminals; Quinolones; Radioligand Assay; Rats; Reserpine; Spiperone; Stereotyped Behavior; Synapses; Tritium | 1995 |